Private Market View

Cureous

Bengaluru, India · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$190K
Last round

Key facts

  • It has raised $190K; the latest was Seed Round ($190K) in Aug 2025.
  • Notable investors include Inflection Point Ventures (India), FirstPort Capital, Anthill Ventures, Kerala Startup Mission, IKP EDEN7 tracked in total.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 7 names
  • ·Watchlist + deal alerts for Cureous
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Cureous are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Cureous

Developer of automated patient care devices designed for improving mobility-impaired patient outcomes and reducing caregiver effort. The company's product offers features such as automated repositioning technology for beds, real-time patient monitoring, and integration with care workflows, enabling healthcare providers and families to prevent complications like bedsores while enhancing comfort and operational efficiency in caregiving.

Sector
Healthcare
HQ
Bengaluru, India
Founded
2019
Employees
9
Ownership
Privately Held (backing)
PA Mark — not yet priced

Cureous doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Cureous shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Cureous in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.